The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2

Council on Pharmacy and Chemistry (American MedicaProject Gutenberg · United StatesDec 2019

Rating 2.7
Word count
1.4M words
Chapters
136

Tags

English Originals Medicine Business DecisionsRisk ControlCivic AwarenessSocial CritiqueMoral DilemmaHealth SciencePolicy AnalysisCase AnalysisDocumentary NarrativeSocial Observation

Summary

Project Gutenberg was the first provider of free electronic books, or eBooks. Michael Hart, founder of Project Gutenberg, invented eBooks in 1971 and his memory continues to inspire the creation of eBooks and related technologies today.The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2Author: Council on Pharmacy and Chemistry (American Medical Association),Language: English, Class: RM: Medicine: Therapeutics, Pharmacology, Release Date: Dec 24, 2014

Editor's review

This is the first volume of the American Medical Association's Council on Pharmacy and Chemistry's propaganda for reform in proprietary medicines, a primary source from the early twentieth-century medical profession's self-scrutiny and public health awakening. Its value lies not in offering modern prescribing guidance but in showing how a professional body of the time used public documents, ingredient analyses, and opinion mobilization to counter exaggerated patent-medicine advertising. Readers can see firsthand the early argumentation, rhetorical strategies, and industry jockeying around drug regulation, which helps illuminate the origins of today's drug labeling, advertising review, and evidence-based medicine. The original is a public-domain English text whose prose bears the marks of its era; some chemical and drug names require contextual understanding. Suitable as supplementary material for medical history, public health history, communication history, and regulatory studies, and for case-based browsing by readers interested in the mechanisms of pseudoscientific promotion.

Who it's for

A good fit for

Not a good fit for

Reading tips

  1. Begin with the introduction or table of contents, mark recurring drug and institution names, then skip-read by theme.
  2. Keep a glossary and note chemical and period trade names as you go to avoid confusion.
  3. Read alongside Volume 2 to observe how the same campaign's arguments shift across materials.
  4. After each chapter, write a three-line summary distinguishing factual statements, industry positions, and rhetorical strategies.

About the publisher

Project Gutenberg United States · Founded in 1971

Project Gutenberg is a digital publishing project focused on public-domain ebooks. Its publishing direction centers on classic literary works whose copyright has expired, covering genres such as poetry, drama, fiction, and epic. Representative books include Lyrical Ballads by Wordsworth and Coleridge, Proust's Du côté de chez Swann, Shakespeare's Macbeth and The Complete Works of William Shakespeare, Homer's The Iliad, Dante's La Divina Comèdia: Purgatòri, Cervantes's The History of Don Quixote, Volume 2, and Grahame's The Wind in the Willows. Its author resources consist mainly of classic Western writers such as Wordsworth, Proust, Shakespeare, Homer, Dante, Cervantes, Grahame, and Tolstoy. Its publishing feature is the provision of freely accessible ebooks in EPUB and Kindle formats; it is not a traditional publisher, and publicly available information is limited.

Contents

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
  124. 124
  125. 125
  126. 126
  127. 127
  128. 128
  129. 129
  130. 130
  131. 131
  132. 132
  133. 133
  134. 134
  135. 135
  136. 136

FAQ

Is this book suitable for learning about modern drug regulation? Not as a direct reader on modern regulations. It reflects primary materials from an early twentieth-century industry group's reform campaign and helps understand the historical starting point and argumentation of regulatory issues, but specific statutes and modern regulatory frameworks require comparison with contemporary sources.
What should I do if the public-domain English text is difficult? Skim the table of contents to locate chapters of interest, use an online dictionary for chemical and trade names, and for long sentences grasp the main clause before filling in modifiers. If you are reading only for research themes, selective thematic reading is more efficient than page-by-page close reading.
Do Volumes 1 and 2 need to be read in order? The two volumes belong to one set of campaign materials with a continuous theme but can be used separately. It is advisable to read Volume 1 first to establish background and core arguments, then Volume 2 to observe the expansion of materials and shifts in argumentation; if time is limited, cross-read selected themes from the contents.

This site is an index: you start “Search all sources” in your browser, and the entries it lists all point to third-party sites; please judge their availability yourself.

About the author

Council on Pharmacy and Chemistry (American Medica Author · American

The Council on Pharmacy and Chemistry (American Medica) was a body under the American Medical Association, chiefly responsible for evaluating the efficacy of drugs and regulating drug advertising. It was not an individual author but a professional organization issuing works under a collective name, with its writing and publishing focused on drug review and on monitoring and exposing the promotion of proprietary medicines. Two of its works are held here, namely volumes 1 and 2 of The Propaganda for Reform in Proprietary Medicines, which address problems in the advertising of proprietary medicines and carry a clear tone of investigation and reform advocacy, offering first-hand material for the study of early twentieth-century American drug regulation and reform opinion within the medical profession. Given the limited sources, details such as its exact founding and active years are not speculated upon here.